CELGENE CORP /DE/ CELG Income Statement

Celgene corp /de/ (CELG)

Income statement / Quarterly

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Sep'08	Jun'08
Revenue:
Total revenue
4,520	4,400	4,025	4,037	3,892	3,814	3,538	3,483	3,287	3,271	2,962	2,980	2,983	2,754	2,512	2,563	2,334	2,277	2,080	2,085	1,982	1,872	1,730	1,755	1,674	1,599	1,464	1,447	1,419	1,366	1,273	1,283	1,249	1,183	1,125	1,071	910	852	791	761	695	628	605	592	571
Royalty revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28	31	28	-	28	26	25	38	26	25	32	28	22	27	29	29	24	28	26	23	25
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
167	151	140	169	157	126	135	119	118	111	113	113	108	111	106	105	109	100	104	103	97	98	86	92	86	80	80	80	74	71	72	77	94	126	127	113	63	67	61	49	52	50	64	70	75
Research and development
1,167	1,100	1,216	1,138	1,081	1,251	2,203	2,738	1,347	835	995	1,135	1,653	949	733	776	1,304	1,110	506	584	675	456	713	731	584	458	452	473	441	447	362	436	356	371	435	327	253	342	204	201	193	218	181	160	144
Selling, general and administrative
781	793	773	850	746	790	864	774	608	939	620	685	698	732	543	608	550	616	529	544	497	491	494	448	448	418	369	370	354	323	325	315	303	305	302	295	228	219	207	211	192	176	173	168	176
Amortization of acquired intangible assets
109	109	109	127	127	127	87	79	80	88	82	105	87	175	92	88	63	63	63	63	63	65	65	65	65	65	65	62	46	44	41	75	75	70	69	68	46	47	41	16	21	22	23	32	35
Acquisition/integration related charges and restructuring, net
32	136	77	-54	101	34	31	-1,425	49	-13	39	13	25	-36	36	84	226	-29	19	37	1	0	8	91	33	12	33	140	0	39	-11	-24	-11	-9	-96	27	7	7	4	-	-	-	0	0	0
Total costs and expenses
2,256	2,289	2,315	2,230	2,212	2,328	3,320	2,285	2,202	1,960	1,849	2,051	2,571	1,931	1,510	1,662	2,254	1,862	1,221	1,333	1,335	1,113	1,368	1,430	1,218	1,035	1,000	1,126	917	925	791	879	818	864	837	830	599	684	521	478	459	468	442	432	431
Operating income
2,264	2,111	1,710	1,807	1,680	1,486	218	1,198	1,085	1,311	1,113	929	412	823	1,002	900	79	415	859	751	646	758	361	325	455	563	463	321	501	441	482	404	431	318	287	240	310	167	270	282	236	160	162	159	139
Other income and (expense):
Interest and investment income, net
45	38	34	15	8	9	13	33	33	24	15	9	7	7	7	4	8	8	9	7	6	7	6	7	5	4	4	5	2	3	3	6	8	5	4	7	12	10	14	14	20	24	17	19	19
Equity in gains (losses) of affiliated companies
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-	-1	-0	-0	0	-0	-0	-0	-2	-1
Interest (expense)
190	192	192	190	193	192	166	142	127	126	127	127	128	123	122	125	88	48	49	51	53	41	29	30	24	19	17	22	17	11	11	11	10	9	11	11	0	0	0	1	0	-0	0	0	1
Other (expense) income, net
-202	-136	262	-515	-117	4	965	42	0	-31	13	-312	-35	-12	35	-35	-19	94	8	3	-22	-17	-6	-85	5	9	-2	-14	-10	7	-0	0	-16	2	6	-16	8	-5	3	7	14	5	32	2	1
Income before income taxes
1,917	1,821	1,814	1,117	1,378	1,307	1,030	1,131	991	1,178	1,014	499	256	695	922	745	-19	470	827	710	577	706	332	217	442	557	448	290	476	440	474	401	412	318	286	221	330	172	288	304	270	189	211	178	158
Income tax provision
226	250	269	44	296	262	184	1,212	3	77	82	70	85	97	121	184	14	114	108	96	69	109	52	2	69	79	63	27	52	73	72	-8	39	39	31	12	49	16	53	50	53	46	48	42	39
Net Income (Loss) Attributable to Parent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	155	234	-	216	142	162	136	119
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
1,691	1,571	1,545	-	1,082	1,045	846	-	988	1,101	932	-	171	598	801	-	-34	356	718	-	508	597	279	-	372	478	384	-	424	367	401	410	372	279	255	209	281	155	234	-	-	-	-	-	-
Net loss attributable to non-controlling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	-0	-0	-	-	-	-	-	-	-	-	-	-
Net income attributable to Celgene
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	410	372	279	255	-	281	-	-	-	-	-	-	-	-
Earnings Per Share [Abstract]
Basic (in dollars per share)
2.38	2.22	2.20	1.52	1.54	1.46	1.13	-0.10	1.26	1.41	1.20	0.55	0.22	0.77	1.03	0.71	-0.04	0.45	0.90	0.76	0.64	0.75	0.34	-0.19	0.45	0.57	0.92	-1.06	0.99	0.84	0.92	0.91	0.83	0.60	0.55	0.44	0.61	0.34	0.51	0.56	0.47	0.31	0.35	0.30	0.27
Diluted (in dollars per share)
2.32	2.16	2.14	1.48	1.50	1.43	1.10	-0.08	1.21	1.36	1.15	0.54	0.21	0.75	0.99	0.69	-0.04	0.43	0.86	0.73	0.61	0.72	0.33	-0.20	0.43	0.56	0.89	-1.04	0.97	0.82	0.90	0.91	0.81	0.59	0.54	0.45	0.60	0.33	0.50	0.54	0.46	0.31	0.35	0.29	0.26
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic (in shares)
709	706	702	698	702	716	748	773	784	780	779	776	775	775	780	785	791	793	798	800	799	799	811	1,240	824	828	417	2,145	427	436	438	440	452	462	465	469	459	460	459	459	458	459	459	456	442
Weighted Average Number of Shares Outstanding, Diluted
729	726	720	714	719	732	768	796	815	811	811	802	801	801	807	849	791	825	834	835	832	831	845	1,294	857	858	432	2,196	436	445	448	449	459	469	472	476	466	467	467	467	467	467	468	468	466
Net product sales
Total revenue
4,518	4,399	4,024	4,036	3,890	3,808	3,531	3,479	3,283	3,259	2,952	2,977	2,969	2,744	2,495	2,539	2,312	2,254	2,055	2,054	1,956	1,844	1,707	1,724	1,644	1,564	1,429	1,415	1,388	1,336	1,245	1,242	1,219	1,154	1,083	1,040	885	823	759	725	667	598	576	567	543
Product and Service, Other [Member]
Total revenue
2	1	1	1	2	6	7	4	4	12	10	3	14	10	17	24	21	23	25	30	25	28	22	119	2	3	7	112	2	3	2	3	3	3	9	3	2	2	2	6	2	2	2	2	2